eLife

Nanoscopy Reveals Heparan Sulfate Clusters as Docking Sites for SARS-CoV-2 Attachment and Entry

Virus entry is thought to involve binding a unique receptor for cell attachment and cytosolic entry. For SARS-CoV-2 underlying the COVID-19 pandemic, angiotensin- converting enzyme 2 (ACE2) is widely ...

How a frozen mammoth named Yuka is redefining the study of ancient RNA

Three of the mammoth samples yielded ancient RNA fragments, particularly the sample from Yuka. Previously assumed to be a female mammoth, their analysis showed that Yuka had fragments of RNA from ...

First Patient Dosed in SYNERGY-101, a Global, Randomized Phase 2 Clinical Trial of STK-012 in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer

Synthekine Inc., an engineered cytokine therapeutics company, today announced that the company has dosed the first patient in the SYNERGY-101 study. SYNERGY-101 is a global, randomized Phase 2 ...

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress

CompletedstrategicpivotfromR&Dfocustocommercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize ...
The Japan Times

'Factory' in cells found to prevent insulin abnormalities

The finding by a group of researchers from Japanese universities, as well as British and South Korean scientists, could help ...

Repairon Announces Positive Clinical Outcomes of Engineered Heart Muscle as Reparative Therapy for Advanced Heart Failure Reported at the Scientific Sessions of the American ...

Yesterday at the Ernest N Morial Convention Center, latest clinical trial findings were disclosed on the use of human engineered heart muscle as biological ventricular assist tissue (BioVAT) ...